Hyderabad (Telangana) [India], January 4 (ANI): The emergency use approval for Covaxin is "a giant leap for innovation and novel product development" in India and the "goal is to provide global access to populations that need it the most", Bharat Biotech chairman and managing director Dr
New Delhi [India], January 4 (ANI): A day after Union Civil Aviation Minister Hardeep Singh Puri called Shashi Tharoor a cynic for criticising the Drugs Controller General of India's (DCGI) approval of COVAXIN for "restricted use in an emergency situation" without this COVID-19 vaccine havin
New Delhi [India], January 4 (ANI): After the drug regulator of the country gave in principle approval for restricted emergency use to two indigenously made vaccines, Bharatiya Janata Party (BJP) spokesperson Sambit Patra on Monday said that when India's scientists develop things for public
New Delhi [India], January 4 (ANI): In its permission to Serum Institute of India for "manufacture for sale or distribution" of COVID-19 vaccine 'Covishield', the DGCI has said that the second dose should be administered between four to six weeks after the first dose and also noted that the
New Delhi [India], January 4 (ANI): A day after the Drugs Controller General of India (DCGI) gave its nod for the emergency use approval for two indigenous vaccines against COVID-19 on Sunday, Vice President M Venkaiah Naidu on Monday termed it as India's leap of science and manifestation
New Delhi [India], January 4 (ANI): The drug regulatory body Drugs Controller General of India (DCGI) has approved Ahmedabad based drug firm Zydus Cadila to initiate Phase III clinical trials of its Covid-19 vaccine ZyCoV-D.
New Delhi [India], January 3 (ANI): Drugs Controller General of India (DCGI) on Sunday said the permission given to Bharat Biotech's COVAXIN is "for restricted use in an emergency situation" and it is given in "public interest as an abundant precaution" as the vaccine is still in clinical tr
Noida (Uttar Pradesh) [India], January 3 (ANI): Kumar Kundan, a journalist who volunteered for human trials of Bharat Biotech's Covid vaccine, refuted rumours about the side effects of "Covaxin" as the Drugs Controller General of India (DCGI) has finally given approval for the vaccine agains
New Delhi [India], January 3 (ANI): India reported 18,177 new COVID-19 cases in the last 24 hours, taking the total number of coronavirus cases in the country to 1,03,23,965, the Union Ministry of Health and Family Welfare (MoHFW) informed on Sunday.
Hyderabad (Telangana) [India], January 3 (ANI): Soon after Prime Minister Narendra Modi applauded the scientists for obtaining emergency use approval from Drugs Controller General of India (DCGI) for indigenous vaccines against COVID-19 on Sunday, the developer of Covaxin, Bharat Biotech,
New Delhi [India], January 3 (ANI): Hours after Drugs Controller General of India (DCGI) approved restricted use in an emergency situation to Bharat Biotech's COVID-19 vaccine, Indian Council of Medical Research (ICMR) on Sunday said data generated through pre-clinical studies and various ph
New Delhi [India], January 3 (ANI): Delhi Chief Minister Arvind Kejriwal congratulated people as the Drugs Controller General of India (DCGI) given approval for the emergency use of two vaccines on Sunday.